Infant technology company Owlet has partnered with telehealth provider Wheel to allow Wheel's clinical staff to prescribe Owlet's FDA-approved, wire-free exclusive product, BabySat, an infant pulse oximetry sock.
Through the partnership, Wheel will manage the BabySat virtual telehealth services platform. Additionally, caregivers can obtain prescriptions for BabySat and the device directly through Wheel's portal or its clinicians. Wheel then works with medical equipment suppliers who can bill insurers for the product, thus easing caregivers' burden.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.